Celaid Therapeutics

Recent Finacing

Series B

Recent Raise

$7M

Celaid Therapeutics is a Tokyo-based biotech developing ex vivo expanded hematopoietic stem-cell therapies and an HSC expansion platform for severe pediatric and genetic diseases.

Tokyo, Japan

1-10

Private

celaidtx.com